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Editorial Comment
Treatment of Right Ventricular
Infarction: Thrombolytic Therapy,
Coronary Angioplasty or Neither?*
ROBERT A. O’ROURKE, MD, FACC
San Antonio, Texas
The beneficial effects of reperfusion therapy in patients with
inferior Q-wave myocardial infarction (IMI) have been less
impressive than in patients with anterior Q-wave MI because
of the lesser amount of myocardium at risk and the lower
mortality rate in patients with IMI (1,2). Thrombolytic therapy
or primary coronary angioplasty should be more successful in
reducing infarct size and decreasing mortality in high risk
patients with IMI. Also relevant, is the lack of definitive
mortality data supporting angioplasty as the primary reperfu-
sion strategy in patients with IMI, unless there are contraindi-
cations to thrombolytic therapy or the patient is in cardiogenic
shock (1).
High Risk Inferior MI Subgroups
Three high risk subsets of patients with IMI have been defined
by simple electrocardiographic (ECG) criteria (1,3–11). These
include patients with associated left precordial ST-segment
depression, particularly when persistent for several hours;
those with third-degree AV block; and those with right pre-
cordial ECG ST-segment elevation indicating the likelihood of
right ventricular (RV) infarction.
The importance of coexisting precordial ST-segment de-
pression in leads V1-V4 in patients with inferior ST-segment
elevation from acute MI has been well documented (3–6). The
available data suggests that thrombolytic therapy or direct
angioplasty is more likely to reduce infarct size and mortality in
patients with IMI when precordial ST-segment depression is
present (12–15).
The mortality rate for patients with third degree AV block
due to IMI has been shown to be higher than in those without
AV block (5,7–9); this is likely due to a larger infarct size
rather than to the conduction abnormality or to associated
multivessel coronary artery disease per se (1,5,9). While third
degree AV block is associated with an increased risk for
mortality, currently there are no data that demonstrate a
definite reduction in the relative risk of mortality with reper-
fusion therapy (1).
Diagnosis of Right Ventricular Infarction
Right ventricular infarction (RVI) occurs in more than 30% of
patients with acute inferior-posterior left ventricular (LV) MI,
the incidence varying depending on the criteria used for its
detection (10,11,16,17). Hemodynamically important RVI is
an uncommon sequela of IMI with the clinical triad of
hypotension, clear lung fields, and elevated jugular venous
pressure occurring in less than 10% of patients presenting with
acute IMI (16,17). With volume loading, the hemodynamic
signs of RVI can be induced in an additional 20% of patients.
The incidence of RVI in different series will vary depending
upon the noninvasive or invasive indicators used for diagno-
sis (18 –22). In various studies ST-segment elevation in
the right-sided precordial leads; the presence of depressed RV
global and regional function by radionuclide or 2D-
echocardiographic techniques; or the presence of RV uptake
of technetium pyrophosphate during infarct avid imaging have
been used as diagnostic criteria (10,11,22). During hemody-
namic measurements, a mean right atrial pressure
$10 mm Hg, a right atrial to left atrial mean pressure ratio of
.0.86 and a systolic pressure #100 mm Hg have been used to
indicate the presence of significant RVI (16,24).
Reduced Susceptibility of the RV to
Infarction
Importantly, many right coronary artery occlusions do not
result in significant RV necrosis and dysfunction (11). This
variance with left coronary artery stenoses may be due in part
to the lesser RV myocardial oxygen demands during an acute
coronary artery occlusion to the lower pressure, thinner walled
ventricle; the greater systolic-diastolic flow ratio in coronary
vessels perfusing the RV; an increased ability of the RV to
extract more oxygen during hemodynamic stress; and the
presence of extensive collateral vessels that protect the RV
from irreversible ischemic damage (11). In detailed postmor-
tem studies three-quarters of all cardiac specimens with RV
necrosis had a .75% stenosis of the left anterior descending
coronary artery, suggesting that diminished left or right collat-
eral blood flow may be involved in the pathogenesis of RVI
(25). However, RVI often occurs in patients with only right
coronary artery stenosis. A recent retrospective study by
Shiraki et al. (26) of 113 patients with a first acute MI due to
right coronary artery occlusion demonstrated a significant
association between preinfarction angina and a lower inci-
dence of RVI. Preinfarction angina was an independent pre-
dictor of the absence of RVI (ST-elevation in V4R) in patients
with acute IMI. Also, patients with preinfarction angina tended
to have a more developed collateral circulation than those
without angina.
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Despite the potentially life-threatening acute hemodynamic
effects, most patients with ischemic RV dysfunction during
acute IMI have spontaneous early hemodynamic improvement
and subsequent recovery of RV function regardless of the
patency of the infarct-related vessel. Nevertheless, RVI is
associated with an increased risk of early morbidity and
mortality in most studies (10,11,27,28).
The RV ejection fraction increases significantly in the
recovery period in survivors after acute RVI and the response
of the RV ejection fraction during exercise is well preserved in
patients 1–3 years after RVI (29). This remarkable capability
of the low pressure, thinner RV to regain systolic function after
MI explains the excellent short and long-term prognosis in
many patients with RVI.
Reperfusion Therapy for RVI
In this issue of the Journal, Zeymer and associates (30)
describe the prognostic impact of RVI in strepokinase-treated
patients with acute IMI stratified to small or large “infarct
size” using the sum of the ST-segment elevation from the 12
lead ECG. Of 522 patients with acute inferior IMI, ST-segment
elevation of $0.1 mV in lead V4R was present in 169 patients
(32%). The higher 30-day cardiac mortality rates in patients
with RVI were related to the larger infarct size and not to the
presence or absence of RIV using multivariant analysis. In this
large multicenter trial, the intensity of the “ischemia” as
measured by the sum of the ST-elevation at baseline was
greater in patients with RVI, both in all patients and in those
with large ST scores. The peak level of creatine kinase (from
multiple enrolling sites) was statistically higher with RVI in all
groups. In 69 patients with RVI undergoing coronary arteriog-
raphy 90 minutes after the initiation of thrombolytic therapy,
the infarct artery was the right coronary artery in all but two.
The authors conclude that reperfusion therapy in IMI patients
presenting with small ST-elevations in the 12 lead ECG, and
thus a “small extent of infarction” probably is not indicated
whether or not RVI is present unless advanced heart block or
hemodynamic instability indicates a larger infarct. However,
there was no noninvasive assessment of LV or RV size or
function in these patients, only those eligible for thrombolytic
therapy were included, and all had thrombolytic therapy within
6 hours of symptom onset.
In a relevant recent study using primary coronary angio-
plasty, Bowers and associates (31) performed echocardio-
graphic studies before and after angioplasty in 53 patients with
acute RVI. RVI was defined by 2-D echocardiographic evi-
dence of ischemic RV dysfunction utilizing the combined
presence of RV free-wall dysfunction, RV dilatation and
depressed global RV function in patients with ST-segment
elevations in leads II, III and AVF. These 53 patients were
selected from a total of 290 patients with IMI who were
screened. The patients presented 1.3–12.4 hours after the
onset of symptoms. Single-vessel disease was present in 29
patients; the culprit lesion was in the right coronary artery in all
cases and proximal to the major RV branches in 94%. Resto-
ration of coronary blood flow in the major RV branches was
successful in 41 patients (77%) and 12 patients had no or
incomplete reperfusion with persistently impaired RV flow.
Before angioplasty, all patients had severe inferior LV dysfunc-
tion but overall LV ejection fraction averaged 50 6 8%.
Untoward in-hospital events occurred more commonly in
patients without successful reperfusion. However, the 58%
mortality rate in those with incomplete reperfusion is very
high, even for those with medically treated RVI. All five
patients with unsuccessful reperfusion who survived to dis-
charge had no subsequent evidence of right heart failure.
Although this study supports the use of primary coronary
angioplasty in patients presenting early after IMI who have
echocardiographic evidence of RVI, it compares a relatively
small number of patients with incomplete reperfusion (recur-
rent intracoronary thrombus or flow-limiting dissections in
several) to patients who had successful reperfusion of the right
coronary artery and its right ventricular branches.
The various different methods used to determine the pres-
ence or absence of RVI; the apparent relative resistance of the
RV to irreversible myocardial ischemia; and the failure to
randomize patients with unequivocal RVI to thrombolytic or
primary angioplasty versus nonreperfusion therapy makes it
difficult to determine which patients with IMI and RVI are
likely to do better with reperfusion therapy as compared to a
more conservative management. There is little information
concerning patients with inferior and RV infarction who
present after the first 12 hours; likely, they will do well
considering the often spontaneous resolution of RV dysfunc-
tion in such patients.
Based on the available information it would seem prudent
that all patients with evidence of an acute IMI have right-sided
precordial ECG leads recorded. Patients with evidence of RVI
by ECG criteria or by other noninvasive measures who have
clinical evidence of depressed RV function are candidates for
coronary angioplasty (if available), thrombolytic therapy (if not
contraindicated), or volume and dobutamine infusion (if nec-
essary) when reperfusion therapy is unavailable or contraindi-
cated. Recent studies indicate that thrombolysis or primary
angioplasty in the first 6 hours after IMI may improve the
short-term survival in many patients with associated RVI.
Randomized trials of thrombolysis versus primary coronary
angioplasty in patients with RV infarction who are not in
cardiogenic shock would further our knowledge concerning the
treatment of RVI and a comparison with RVI patients treated
more conservatively would be useful in determining the cost
effectiveness of different treatment strategies for patients with
RVI.
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